Establishes all-payer claims database.
A5087 would require the New Jersey Department of Health to establish and administer an all-payer claims database. The database would collect and store a broad set of health care data, including medical claims, behavioral health claims, prescription drug claims, dental and vision claims, eligibility and enrollment information, provider information, and certain non-claims payments to providers. The bill also directs the department to oversee implementation, secure and format the data, audit submissions for accuracy, and publish selected information on a public dashboard.
The bill is designed to support health care transparency and analysis. It would allow approved researchers and research institutions to access database data under specified conditions, including institutional review board approval and confidentiality protections. The department would also use the data to help covered persons compare the cost and quality of health care services, and the bill requires inclusion of a unique longitudinal identifier to track utilization over time. Reporting entities would be required to submit data once reporting rules are adopted, while self-insured ERISA plans could voluntarily participate to the extent allowed by federal law.
The bill would add a new statutory framework in Title 17B for a statewide all-payer claims database and would expand the Department of Health’s responsibilities in collecting, analyzing, and publicly reporting health care claims data. It would impose reporting obligations on carriers, health care providers, pharmacy benefits managers, and third-party administrators, while excluding self-insured ERISA plans from mandatory reporting. The bill also authorizes the Commissioner of Health to assess civil penalties of up to $1,000 per day for noncompliance and requires the department to adopt implementing regulations in consultation with the Department of Banking and Insurance.
No committee transcripts or recorded votes were provided, so there is no documented floor or committee sentiment to summarize. Based on the bill text, the measure appears policy-driven and administrative in nature, with an emphasis on transparency, data collection, and consumer decision-making. The absence of recorded opposition or amendments in the provided materials suggests no clear public controversy is reflected in the available record.
The main potential points of contention are likely to be data privacy, administrative burden, and federal preemption issues. The bill requires collection and publication of sensitive health claims information, though it includes confidentiality protections and limits on public disclosure. Reporting entities, including carriers, providers, PBMs, and TPAs, may object to the cost and complexity of compliance, especially because the department may audit submissions and impose daily penalties. Another likely issue is the treatment of self-insured ERISA plans, which are excluded from mandatory reporting and may only participate voluntarily, reflecting the bill’s effort to avoid conflict with federal law.